source
- Patient dies in Bristol Myers Squibb autoimmune CAR-T trial, raising safety concernsBristol Myers Squibb reported that a participant in its Phase 1 CAR-T study for multiple sclerosis died. The trial was testing an investigational CAR-T therapy aimed at autoimmune disease. The pat…
- Roche warns Germany faces last chance to regain pharma investment confidenceRoche has said that recent German healthcare reforms threaten the country's attractiveness for pharmaceutical investment. The company paused its own German investment plans after the reforms were a…